MicroRNAs and cancer: Key paradigms in molecular therapy.
about
Upregulated hsa_circ_0004458 Contributes to Progression of Papillary Thyroid Carcinoma by Inhibition of miR-885-5p and Activation of RAC1Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal CancerSunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals
P2860
MicroRNAs and cancer: Key paradigms in molecular therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
MicroRNAs and cancer: Key paradigms in molecular therapy.
@en
MicroRNAs and cancer: Key paradigms in molecular therapy.
@nl
type
label
MicroRNAs and cancer: Key paradigms in molecular therapy.
@en
MicroRNAs and cancer: Key paradigms in molecular therapy.
@nl
prefLabel
MicroRNAs and cancer: Key paradigms in molecular therapy.
@en
MicroRNAs and cancer: Key paradigms in molecular therapy.
@nl
P2093
P2860
P356
P1433
P1476
MicroRNAs and cancer: Key paradigms in molecular therapy.
@en
P2093
P2860
P304
P356
10.3892/OL.2017.7638
P577
2017-12-19T00:00:00Z